<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02820467</url>
  </required_header>
  <id_info>
    <org_study_id>38RC15.212</org_study_id>
    <nct_id>NCT02820467</nct_id>
  </id_info>
  <brief_title>Use of Indocyanine Green Angiography in Critical Limb Ischemia</brief_title>
  <acronym>FLUORESCENCE</acronym>
  <official_title>Study of Parameters of Infracyanine Angiography as Diagnostic Tool of Critical Limb Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators conduct a monocentric pilot study with the objective to determine the
      hemodynamic parameter of fluorescence angiography (slope, amplitude, saturation time ) best
      correlated with toe pressure in patients with suspicion of critical limb ischemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Critical limb ischemia, defined as the presence of chronic ischemic rest pain, ulcers or
      gangrene attributable to objectively proven arterial occlusive disease, is associated with
      the appalling prospect that approximately 30% will lose their leg and 25% will die at one
      year. Despite the progress of therapeutics these statistics haven't changed. Critical limb
      ischemia is a clinical diagnosis but should be supported by objective tests. None of theses
      tests (toe blood pressure (TBP), transcutaneous oxygen pressure (TcPO2) and skin perfusion
      pressure (SPP)) have proven to be enough specific or sensitive, more so they are time
      consuming, can be subject to several artifacts and may be in some cases discordant making
      diagnosis difficult. Fluorescence angiography has long been used in ophthalmology for the
      evaluation of the microcirculation of the retina. Infracyanine remains within the
      intravascular space allowing the visualization of the vasculature to a depth of 10 mm. With
      the Fluobeam system, images to a maximal width of 20 cm can be obtained therefore allowing
      the evaluation of the tissue perfusion of the entire foot.

      Method: Fluorescence angiography is performed in the laboratory in the same time as TCPO2, TP
      and SPP. Infracyanine is injected in an antecubital vein and visualization and signal
      acquisition carried out using a specific camera device (Fluoptic SAS, France) producing the
      time course of hemodynamic parameters (slope, amplitude, saturation time).

      30patients will be evaluated with correlation between data obtained by fluorescence
      angiography and too blood pressure
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve ( saturation time (s) with toe pressure (mm hg) assessed by laser doppler</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve ( amplitude (UA) with toe pressure (mm hg) assessed by laser doppler</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve ( slope) with toe pressure (mm hg) assessed by laser doppler</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve ( saturation time (s) with transcutaneous cutaneous pressure of oxygen (mm Hg)</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve ( amplitude (UA) with transcutaneous cutaneous pressure of oxygen (mm Hg)</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of parameters of fluorescence on time intensity curve (slope) with transcutaneous cutaneous pressure of oxygen (mm Hg)</measure>
    <time_frame>instantaneous, at the time the exam is performed</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>patients with suspicion of CLI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients presenting with peripheral artery disease and suspicion of critical limb ischemia as assessed by TASK II consensus 30 patients will be enrolled and will benefit of measures of TcPO2, too systolic blood pressure and skin perfusion pressure and in the same time angiography with fluorescence (Indocyanine grey 0.05 mg/kg by intravenous injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fluorescence angiography</intervention_name>
    <description>Injection of indocyanine grey in an antecubital vein at the posology of 0.05 mg/kg</description>
    <arm_group_label>patients with suspicion of CLI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with peripheral artery disease and suspicion of critical limb ischemia

        Exclusion Criteria:

          -  pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>christophe seinturier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Grenoble france</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>christophe seinturier, MD</last_name>
    <phone>0033476765547</phone>
    <email>cseinturier@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>christophe seinturier</last_name>
      <phone>0033476765547</phone>
      <email>cseinturier@chu-grenoble.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Becker F, Robert-Ebadi H, Ricco JB, Setacci C, Cao P, de Donato G, Eckstein HH, De Rango P, Diehm N, Schmidli J, Teraa M, Moll FL, Dick F, Davies AH, Lepäntalo M, Apelqvist J. Chapter I: Definitions, epidemiology, clinical presentation and prognosis. Eur J Vasc Endovasc Surg. 2011 Dec;42 Suppl 2:S4-12. doi: 10.1016/S1078-5884(11)60009-9. Review.</citation>
    <PMID>22172472</PMID>
  </reference>
  <reference>
    <citation>Bloch C, Richard JL. [Risk factors for atherosclerotic diseases in the Prospective Parisian Study I. Comparison with foreign studies]. Rev Epidemiol Sante Publique. 1985;33(2):108-20. Review. French.</citation>
    <PMID>3898252</PMID>
  </reference>
  <reference>
    <citation>Braun JD, Trinidad-Hernandez M, Perry D, Armstrong DG, Mills JL Sr. Early quantitative evaluation of indocyanine green angiography in patients with critical limb ischemia. J Vasc Surg. 2013 May;57(5):1213-8. doi: 10.1016/j.jvs.2012.10.113. Epub 2013 Jan 24.</citation>
    <PMID>23352361</PMID>
  </reference>
  <reference>
    <citation>Chung J, Modrall JG, Valentine RJ. The need for improved risk stratification in chronic critical limb ischemia. J Vasc Surg. 2014 Dec;60(6):1677-85. doi: 10.1016/j.jvs.2014.07.104. Epub 2014 Sep 8. Review.</citation>
    <PMID>25214365</PMID>
  </reference>
  <reference>
    <citation>Ciardella AP, Prall FR, Borodoker N, Cunningham ET Jr. Imaging techniques for posterior uveitis. Curr Opin Ophthalmol. 2004 Dec;15(6):519-30. Review.</citation>
    <PMID>15523198</PMID>
  </reference>
  <reference>
    <citation>Constans J, Bura-Rivière A. [Lower limb occlusive arterial disease: Diagnosis problems in 2014]. Presse Med. 2014 Jul-Aug;43(7-8):823-6. doi: 10.1016/j.lpm.2014.03.013. Epub 2014 Jun 2. French.</citation>
    <PMID>24890636</PMID>
  </reference>
  <reference>
    <citation>Cull DL, Manos G, Hartley MC, Taylor SM, Langan EM, Eidt JF, Johnson BL. An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system. J Vasc Surg. 2014 Dec;60(6):1535-41. doi: 10.1016/j.jvs.2014.08.107. Epub 2014 Oct 3.</citation>
    <PMID>25282695</PMID>
  </reference>
  <reference>
    <citation>Elsayed S, Clavijo LC. Critical limb ischemia. Cardiol Clin. 2015 Feb;33(1):37-47. doi: 10.1016/j.ccl.2014.09.008. Review.</citation>
    <PMID>25439329</PMID>
  </reference>
  <reference>
    <citation>Terasaki H, Inoue Y, Sugano N, Jibiki M, Kudo T, Lepäntalo M, Venermo M. A quantitative method for evaluating local perfusion using indocyanine green fluorescence imaging. Ann Vasc Surg. 2013 Nov;27(8):1154-61. doi: 10.1016/j.avsg.2013.02.011. Epub 2013 Aug 20.</citation>
    <PMID>23972435</PMID>
  </reference>
  <reference>
    <citation>Igari K, Kudo T, Toyofuku T, Jibiki M, Inoue Y, Kawano T. Quantitative evaluation of the outcomes of revascularization procedures for peripheral arterial disease using indocyanine green angiography. Eur J Vasc Endovasc Surg. 2013 Oct;46(4):460-5. doi: 10.1016/j.ejvs.2013.07.016. Epub 2013 Aug 21.</citation>
    <PMID>23973274</PMID>
  </reference>
  <reference>
    <citation>Kang Y, Lee J, Kwon K, Choi C. Application of novel dynamic optical imaging for evaluation of peripheral tissue perfusion. Int J Cardiol. 2010 Dec 3;145(3):e99-101. doi: 10.1016/j.ijcard.2008.12.166. Epub 2009 Feb 23.</citation>
    <PMID>19230993</PMID>
  </reference>
  <reference>
    <citation>Kang Y, Lee J, Kwon K, Choi C. Dynamic fluorescence imaging of indocyanine green for reliable and sensitive diagnosis of peripheral vascular insufficiency. Microvasc Res. 2010 Dec;80(3):552-5. doi: 10.1016/j.mvr.2010.07.004. Epub 2010 Jul 15.</citation>
    <PMID>20637783</PMID>
  </reference>
  <reference>
    <citation>Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985 Jan;33(1):13-8.</citation>
    <PMID>3965550</PMID>
  </reference>
  <reference>
    <citation>Labs KH, Dormandy JA, Jaeger KA, Stuerzebecher C, Hiatt WR. Trans-atlantic conference on clinical trial guidelines in PAOD (Peripheral arterial occlusive disease) clinical trial methodology. Eur J Vasc Endovasc Surg. 1999 Sep;18(3):253-65.</citation>
    <PMID>10480800</PMID>
  </reference>
  <reference>
    <citation>Levesque E, Hoti E, Azoulay D, Adam R, Samuel D, Castaing D, Saliba F. Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation. Clin Transplant. 2011 Mar-Apr;25(2):297-301. doi: 10.1111/j.1399-0012.2010.01252.x.</citation>
    <PMID>20412097</PMID>
  </reference>
  <reference>
    <citation>Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75. Epub 2006 Nov 29.</citation>
    <PMID>17140820</PMID>
  </reference>
  <reference>
    <citation>Pestana IA, Coan B, Erdmann D, Marcus J, Levin LS, Zenn MR. Early experience with fluorescent angiography in free-tissue transfer reconstruction. Plast Reconstr Surg. 2009 Apr;123(4):1239-44. doi: 10.1097/PRS.0b013e31819e67c1.</citation>
    <PMID>19337092</PMID>
  </reference>
  <reference>
    <citation>Rashid H, Slim H, Zayed H, Huang DY, Wilkins CJ, Evans DR, Sidhu PS, Edmonds M. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J Vasc Surg. 2013 May;57(5):1219-26. doi: 10.1016/j.jvs.2012.10.129. Epub 2013 Mar 21.</citation>
    <PMID>23523278</PMID>
  </reference>
  <reference>
    <citation>Schaafsma BE, Mieog JS, Hutteman M, van der Vorst JR, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011 Sep 1;104(3):323-32. doi: 10.1002/jso.21943. Epub 2011 Apr 14. Review.</citation>
    <PMID>21495033</PMID>
  </reference>
  <reference>
    <citation>Yamada T, Ohta T, Ishibashi H, Sugimoto I, Iwata H, Takahashi M, Kawanishi J. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs--comparison with other noninvasive diagnostic methods. J Vasc Surg. 2008 Feb;47(2):318-23. doi: 10.1016/j.jvs.2007.10.045.</citation>
    <PMID>18241755</PMID>
  </reference>
  <reference>
    <citation>Zimmermann A, Roenneberg C, Reeps C, Wendorff H, Holzbach T, Eckstein HH. The determination of tissue perfusion and collateralization in peripheral arterial disease with indocyanine green fluorescence angiography. Clin Hemorheol Microcirc. 2012;50(3):157-66. doi: 10.3233/CH-2011-1408.</citation>
    <PMID>22240349</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>March 16, 2017</last_update_submitted>
  <last_update_submitted_qc>March 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Indocyanine</keyword>
  <keyword>Angiography</keyword>
  <keyword>Ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

